Analysts have clear opinions on IRTC.
There are 6 analysts on the Wall offering 12 month price targets for Irhythm Technologies in the last 3 months. The average price target is $107.00 with a high forecast of $110.00 and a low forecast of $102.00. The average price target represents a 28.99% increase from the last price of $82.95.
iRhythm Technologies, Inc. (IRTC) is followed by 6 analysts on the street.
Margaret Kaczor from William Blair rates it a Buy.
Similarly, 14 days ago Kaila Krum of SunTrust Robinson Initiated a Buy with a target of $102.00.
The consensus on the street is Strong Buy.
What does iRhythm Technologies, Inc.(IRTC) do ?
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
iRhythm Technologies, Inc. (IRTC) Insider Trades
Multiple company employees have indulged in significant insider trading. iRhythm Technologies, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):
CFO, Garrett Matthew C. : S – Sale+OE(-$2,295,760) of IRTC in the trading session of 2020-01-15.
Pres, CEO King Kevin M : S – Sale+OE(-$2,576,720) of IRTC in the trading session of 2020-01-15.
CFO Garrett Matthew C. : S – Sale+OE(-$396,320) of iRhythm Technologies, Inc. in the trading session of 2020-01-14.
Looking for stocks just like IRTC?
Based on Wall Street analyst research, several stocks are similar to IRTC
– OSIS [Info can be found here: https://www.nasdaq.com/market-activity/stocks/OSIS ]
– ABT [Info can be found here: https://www.nasdaq.com/market-activity/stocks/ABT ]
– BSX [Info can be found here: https://www.nasdaq.com/market-activity/stocks/BSX ]